Prestige BioPharma Ratios and Metrics

Market cap in millions KRW. Fiscal year is July - June.

Millions KRW. Fiscal year is Jul - Jun.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb '25 Feb 12, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021	Jun '20 Jun 30, 2020
Market Capitalization	175,841	103,966	113,582	137,620	396,635	-
Market Cap Growth	38.89%	-8.47%	-17.47%	-65.30%	-	-
Enterprise Value	170,895	44,042	-6,736	-150,494	-63,944	-
Last Close Price	14630.00	8650.00	9450.00	11450.00	33000.00	-
PE Ratio	-	-	6.46	-	-	-
Forward PE	-	12.01	12.01	12.01	-	-
PS Ratio	63.41	150.88	701.81	-	-	-
PB Ratio	2.35	0.20	0.21	0.32	0.69	-
P/TBV Ratio	0.53	0.26	0.28	0.32	0.69	-
EV/Sales Ratio	60.10	63.91	-	-	-	-
Debt / Equity Ratio	0.23	0.20	0.21	0.01	0.01	0.02
Debt / EBITDA Ratio	-	-	9.11	-	-	-
Asset Turnover	0.00	0.00	0.00	-	-	-
Inventory Turnover	0.09	0.10	0.01	-	-	-
Quick Ratio	1.28	1.57	2.24	7.26	32.70	5.71
Current Ratio	1.41	1.72	2.31	7.45	32.74	5.88
Return on Equity (ROE)	-9.51%	-10.38%	-0.59%	-42.08%	-2.07%	-
Return on Assets (ROA)	-5.20%	-5.35%	0.10%	-13.89%	-3.01%	-
Return on Capital (ROIC)	-6.18%	-6.07%	0.12%	-15.08%	-3.18%	-
Return on Capital Employed (ROCE)	-	-	0.17%	-	-	-
Earnings Yield	-16.83%	-31.67%	15.47%	-153.65%	-1.86%	-
FCF Yield	-48.03%	-65.49%	-95.65%	-74.36%	-4.13%	-
Buyback Yield / Dilution	-0.42%	-	-	-16.46%	-20.98%	-
Total Shareholder Return	-0.42%	-	-	-16.46%	-20.98%	-

Source: S&P Capital IQ. Standard template. Financial Sources.